Yoshinori Shirasaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yoshinori Shirasaka has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Akira Nishizono
Department of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan
1 shared publication - Daisuke Ueo
UEO Dermatology Clinic
1 shared publication - Fumitaka Yoshizumi
Nankai Medical Center, Saiki, Japan
1 shared publication - Katsuhiro Ogawa
Department of Gastroenterological and Pediatric Surgery Oita University Faculty of Medicine Oita Japan
1 shared publication - Kazuko Noguchi
Laboratory of Veterinary Public Health, Department of Veterinary Sciences, Faculty of Agriculture, University of Miyazaki, 1-1 Gakuenkibanadai-Nishi, Miyazaki City 889-2192, Miyazaki, Japan
1 shared publication - Kentaro Yamada
Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke-shi 329-0498, Tochigi, Japan
1 shared publication
Latest Publications
- Open Access
- 8 January 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (1) , 79
Cytocidal Effect of Irradiation on Gastric Cancer Cells Infected with a Recombinant Mammalian Orthoreovirus Expressing a Membrane-Targeted KillerRed
The outcomes of unresectable gastric cancer (GC) are unfavorable even with chemotherapy; therefore, a new treatment modality is required. The combination of an oncolytic virus and photodynamic therapy can be one of the promising modalities to overcome this. Mammalian orthoreovirus (MRV) is an oncolytic virus that has been used in clinical trials for several cancers. In this study, we developed and evaluated a recombinant MRV strain type 3 Dearing (T3D) that expresses membrane-targeting KillerRed (KRmem), a phototoxic fluorescent protein that produces cytotoxic reactive oxygen species upon light irradiation. KRmem was fused in-frame to the 3′ end of the σ2 viral gene in the S2 segment using a 2A peptide linker, enabling the expression of multiple proteins from a single transcript. RNA electrophoresis, Western blotting, and immunofluorescence analyses confirmed functional insertion of KRmem into the recombinant virus. The growth activity of the recombinant virus was comparable to that of the wild-type MRV in a cultured cell line. The recombinant virus infected two GC cell lines (MKN45P and MKN7), and a significant cytocidal effect was observed in MKN45P cells infected with the recombinant virus after light irradiation. Thus, recombinant MRV-expressing KRmem has the potential to serve as a novel treatment tool for GC.
- 8 January 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (1) , 79
Open AccessCytocidal Effect of Irradiation on Gastric Cancer Cells Infected with a Recombinant Mammalian Orthoreovirus Expressing a Membrane-Targeted KillerRed
The outcomes of unresectable gastric cancer (GC) are unfavorable even with chemotherapy; therefore, a new treatment modality is required. The combination of an oncolytic virus and photodynamic therapy can be one of the promising modalities to overcome this. Mammalian orthoreovirus (MRV) is an oncolytic virus that has been used in clinical trials for several cancers. In this study, we developed and evaluated a recombinant MRV strain type 3 Dearing (T3D) that expresses membrane-targeting KillerRed (KRmem), a phototoxic fluorescent protein that produces cytotoxic reactive oxygen species upon light irradiation. KRmem was fused in-frame to the 3′ end of the σ2 viral gene in the S2 segment using a 2A peptide linker, enabling the expression of multiple proteins from a single transcript. RNA electrophoresis, Western blotting, and immunofluorescence analyses confirmed functional insertion of KRmem into the recombinant virus. The growth activity of the recombinant virus was comparable to that of the wild-type MRV in a cultured cell line. The recombinant virus infected two GC cell lines (MKN45P and MKN7), and a significant cytocidal effect was observed in MKN45P cells infected with the recombinant virus after light irradiation. Thus, recombinant MRV-expressing KRmem has the potential to serve as a novel treatment tool for GC.
- Open Access
- 1 January 2019
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 31 (Suppl) , S56-+
Possible Involvement of Cancer Producing Thymic Stromal Lymphopoietin as an Initiator of Papuloerythroderma of Ofuji
- 1 January 2019
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 31 (Suppl) , S56-+
Open AccessPossible Involvement of Cancer Producing Thymic Stromal Lymphopoietin as an Initiator of Papuloerythroderma of Ofuji
- Open Access
- 1 January 2016
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 77 (11) , 2738-2742
A Case of Perforated Appendicitis that Formed an Abscess in an Inguinal Hernia Sac
- 1 January 2016
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 77 (11) , 2738-2742
Open AccessA Case of Perforated Appendicitis that Formed an Abscess in an Inguinal Hernia Sac